Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the
SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech
Dr. Ryan Mitchell, PhD and Director of Business Development to highlight Satellos' novel muscle regeneration technology on June 15Toronto, Ontario--(Newsfile Corp. - June 14, 2022) - Satellos Bioscience
DehydraTECH Pharmaceutical License Issued for the European, Australian and New Zealand marketsLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 8, 2022 /
Comprehensive in vitro pro-arrhythmia assay used to validate Axol's cardiomyocytes for cardiac safety testing Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and